Maria Jesus Gonzalez-Rellan

Maria Jesus Gonzalez-Rellan

scientist Spain

Maria Jesus Gonzalez-Rellan is a postdoctoral researcher in Dr. Daniel Drucker’s lab at Mount Sinai Hospital, originally from Spain. She is investigating the mechanisms by which semaglutide improves liver function in patients with metabolic dysfunction-associated steatohepatitis (MASH), revealing important insights into weight-loss independent benefits of GLP-1 receptor agonists.

Global Media Ratings
Dominance
0.00%
Persistence
0 wks
Reach
0
Power
0$
Sentiment
0.00
Countries Mentioned

No country-level mention data available.

Interactive World Map

Each country's color is based on "Mentions" from the table above.

Recent Mentions

Canada Canada: Dr. Maria Jesus Gonzalez-Rellan has been experimenting on mice to figure out why semaglutide improves liver function in people with severe fatty liver disease. 8

The Globe and Mail: The Canadian researcher whose discovery led to Ozempic is still making breakthroughs